Drug recall · November 29, 2017
Pravastatin Sodium USP recall
Why: Presence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a Pravastatin Sodium Tablets USP, 40mg bottle.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Pravastatin Sodium USP, tablets, 40 mg, 90-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-487-09
- Lots / codes
Lot # G702459, Exp 2/20
- Quantity
- N/A
- Company
- Lupin Limited, Vasco Da Gama, N/A
- Distribution
- Product was distributed throughout the United States, including Puerto Rico.
- Initiated
- November 17, 2017 · Voluntary: Firm initiated
- Classified
- November 21, 2017
- Reported
- November 29, 2017
- Ended
- March 15, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pravastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.